Results
203
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
203 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ONON | US$59.90 | 3.3% | 117.9% | US$19.3b | US$62.47 | PE137.2x | E29.7% | n/a | Consumer Durables | ||
KINS | US$14.70 | -4.4% | 359.4% | US$188.1m | US$18.00 | PE11.4x | E24.9% | 0% | Insurance | ||
ATAT | US$27.09 | 4.8% | 52.6% | US$3.8b | US$33.33 | PE23.2x | E25.2% | 1.7% | Consumer Services | ||
TBBB | US$31.21 | 5.8% | n/a | US$3.5b | US$33.79 | PE277.5x | E40.4% | n/a | Consumer Retailing | ||
SMCI | US$29.07 | -10.4% | -43.3% | US$17.0b | US$40.79 | PE14.1x | E24.3% | n/a | Tech | ||
CACC | US$524.11 | 8.1% | -6.0% | US$6.3b | US$436.50 | PE33.5x | E48.0% | n/a | Diversified Financials | ||
CLNN | US$4.52 | -5.6% | -56.1% | US$39.4m | US$45.17 | PS85.7x | E59.1% | n/a | Pharmaceuticals & Biotech | ||
MYO | US$5.66 | -7.2% | 70.0% | US$200.8m | US$7.67 | PS7.5x | E56.7% | n/a | Healthcare | ||
RH | US$411.00 | -8.1% | 50.4% | US$7.8b | US$451.54 | PE109.4x | E53.8% | n/a | Retail | ||
RYAN | US$65.36 | -1.9% | 48.6% | US$16.6b | US$73.98 | PE80.4x | E43.9% | 0.7% | Insurance | ||
DUOT | US$5.71 | -1.6% | 25.8% | US$55.4m | US$8.75 | PS6.5x | E90.4% | n/a | Software | ||
CARG | US$38.99 | 3.2% | 63.4% | US$4.0b | US$39.88 | PS4.5x | E42.4% | n/a | Media | ||
OSTX | US$2.50 | -15.3% | n/a | US$57.1m | US$14.67 | PE-7.2x | E23.8% | n/a | Pharmaceuticals & Biotech | ||
NEON | US$8.25 | 3.5% | 397.0% | US$145.3m | US$10.25 | PS36.5x | E110.9% | n/a | Tech | ||
TRUG New | US$0.52 | -7.9% | -93.5% | US$11.9m | US$2.50 | PS0.5x | E58.0% | n/a | Media | ||
CBNK | US$29.51 | 1.5% | 28.5% | US$479.5m | US$32.00 | PB1.7x | E30.1% | 1.4% | Banks | ||
WULF | US$4.43 | -30.8% | 135.6% | US$2.4b | US$9.83 | PS13.2x | E49.4% | n/a | Software | ||
SMWB | US$15.77 | 0.8% | 141.5% | US$1.4b | US$15.25 | PS5.3x | E126.3% | n/a | Software | ||
CRDO | US$55.60 | -31.8% | 165.0% | US$9.3b | US$79.54 | PS37.9x | E66.2% | n/a | Semiconductors | ||
ZS | US$191.24 | 2.0% | -22.0% | US$29.7b | US$226.04 | PS12.8x | E39.7% | n/a | Software | ||
MP | US$21.52 | 2.8% | 32.0% | US$3.5b | US$23.55 | PS19.1x | E82.9% | n/a | Materials | ||
EH | US$16.45 | 5.8% | 33.0% | US$1.0b | US$24.18 | PS21.7x | E81.2% | n/a | Capital Goods | ||
SPOT | US$513.98 | 5.9% | 135.1% | US$103.1b | US$493.31 | PE141.3x | E29.8% | n/a | Media | ||
SPRY | US$14.45 | 15.0% | 123.0% | US$1.4b | US$27.25 | PS546.9x | E58.7% | n/a | Pharmaceuticals & Biotech |